Phi Therapeutics, Inc.
Biotechnology company · Petaluma, California, United States
Phi Therapeutics, Inc. is a biotechnology company headquartered in Petaluma, California, United States. It has received 1 US government small-business research award (SBIR/STTR) from health agencies, $164,724 in total, most recently in 2015. It has reported private securities offerings to the US SEC, most recently $7.7 million sold in a notice filed in 2024.
Phi Therapeutics at a glance
What does Phi Therapeutics do?
US government research funding
1 SBIR/STTR small-business research award from US health agencies, $164,724 in total (2015).
Private fundraising reported to the SEC
4 Form D notices; the most recent reported $7.7 million sold (2024).
Frequently asked questions about Phi Therapeutics
Where is Phi Therapeutics headquartered?
Phi Therapeutics, Inc. is headquartered in Petaluma, California, United States.
What does Phi Therapeutics do?
Phi Therapeutics, Inc. is a biotechnology company.
Similar companies
- Dow Pharmaceutical SciencesPetaluma, California, United States
- Recursion PharmaceuticalsSalt Lake City, Utah, United States
- Vericel CorpBurlington, Massachusetts, United States
- SAB Biotherapeutics, Inc.Miami Beach, Florida, United States
- Adaptive Biotechnologies CorpSeattle, Washington, United States
- Inhibikase Therapeutics, Inc.Wilmington, Delaware, United States
- Cognition Therapeutics IncPurchase, New York, United States
- Agenus IncLexington, Massachusetts, United States
Need a CRO or CDMO for your next study?
Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.
Compare quotesLast updated 2026-09-23. Data licences